
1. Viruses. 2016 Aug 5;8(8). pii: E212. doi: 10.3390/v8080212.

Hepatitis E Pathogenesis.

Lhomme S(1), Marion O(2)(3), Abravanel F(4), Chapuy-Regaud S(5), Kamar N(6),
Izopet J(7).

Author information: 
(1)INSERM, UMR1043, Department of Virology, CHU Purpan, Université Paul Sabatier,
31000 Toulouse, France. lhomme.s@chu-toulouse.fr.
(2)INSERM, UMR1043, Department of Virology, CHU Purpan, Université Paul Sabatier,
31000 Toulouse, France. marion-olivier@hotmail.fr.
(3)INSERM, UMR1043, Department of Nephrology, Dialysis and Organ Transplantation,
CHU Rangueil, Université Paul Sabatier, 31000 Toulouse, France.
marion-olivier@hotmail.fr.
(4)INSERM, UMR1043, Department of Virology, CHU Purpan, Université Paul Sabatier,
31000 Toulouse, France. abravanel.f@chu-toulouse.fr.
(5)INSERM, UMR1043, Department of Virology, CHU Purpan, Université Paul Sabatier,
31000 Toulouse, France. chapuy-regaud.s@chu-toulouse.fr.
(6)INSERM, UMR1043, Department of Nephrology, Dialysis and Organ Transplantation,
CHU Rangueil, Université Paul Sabatier, 31000 Toulouse, France.
kamar.n@chu-toulouse.fr.
(7)INSERM, UMR1043, Department of Virology, CHU Purpan, Université Paul Sabatier,
31000 Toulouse, France. izopet.j@chu-toulouse.fr.

Although most hepatitis E virus (HEV) infections are asymptomatic, some can be
severe, causing fulminant hepatitis and extra-hepatic manifestations, including
neurological and kidney injuries. Chronic HEV infections may also occur in
immunocompromised patients. This review describes how our understanding of the
pathogenesis of HEV infection has progressed in recent years.

DOI: 10.3390/v8080212 
PMCID: PMC4997574
PMID: 27527210  [Indexed for MEDLINE]

